本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ovid Therapeutics Inc.

1.43
-0.0200-1.38%
成交量:24.16萬
成交額:34.58萬
市值:1.02億
市盈率:-2.67
高:1.47
開:1.43
低:1.38
收:1.45
52周最高:2.01
52周最低:0.2425
股本:7,110.95萬
流通股本:5,952.45萬
量比:0.92
換手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-0.5359
每股收益(LYR):-0.3663
淨資產收益率:-52.77%
總資產收益率:-26.71%
市淨率:1.82
市盈率(LYR):-3.90

資料載入中...

2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, items 8.01 and 9.01
2019/12/24

重要事件披露

Current report, item 5.02
2019/11/27

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/22

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/22

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/08

重要事件披露

Current report, items 2.02 and 9.01
2019/11/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/01

重要事件披露

Current report, items 5.01, 8.01, and 9.01
2019/10/08

重要事件披露

Current report, items 8.01 and 9.01
2019/10/07

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/24

重要事件披露

Current report, items 5.03 and 9.01
2019/09/23

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2019/09/19

重要事件披露

Current report, items 3.02, 5.03, 5.07, and 9.01
2019/09/12

重要事件披露

Current report, items 8.01 and 9.01
2019/09/09

重要事件披露

Current report, items 8.01 and 9.01